CTCBIO Inc. (KOSDAQ:060590)
South Korea
· Delayed Price · Currency is KRW 5,120.00
-50.00 (-0.97%)
At close: Dec 5, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
| Animal and Human Medicine | 127.63B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Animal and Human Medicine Growth | 9.69% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Hay | 24.53B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Hay Growth | -1.62% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Health Functional Food | 859.05M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Health Functional Food Growth | -53.51% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Consolidated Adjustment | -8.61B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Consolidated Adjustment Growth | 63.89% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Consolidated Adjustment | -8.61B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Consolidated Adjustment Growth | 63.89% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
| Consolidated Adjustment | -8.61B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Consolidated Adjustment Growth | 63.89% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South Korea | 152.07B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South Korea Growth | 7.63% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Overseas | 950.43M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Overseas Growth | -48.56% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Consolidated Adjustment | -8.61B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Consolidated Adjustment Growth | 63.89% |
Log In |
Log In |
Log In |
Log In | Upgrade
|